Tweet
Reuters |
US DOJ Closes Probe Into AstraZeneca's Heart Drug Brilinta Wall Street Journal Brilinta was approved in the U.S. in 2011, but the Justice Department cast doubts over the future of the drug last October when it decided to investigate a key clinical trial that demonstrated Brilinta's benefits over a rival treatment. Brilinta is clot-busting drug that ... AstraZeneca tops FTSE 100Financial Times US clears AstraZeneca over heart drug trialReuters US DOJ Closes Probe Into Plato AstraZeneca TrialNASDAQ London South East all 25 news articles » |
More...